scholarly journals Social validity of randomised controlled trials in health services research and intellectual disabilities: a qualitative exploration of stakeholder views

Trials ◽  
2011 ◽  
Vol 12 (1) ◽  
Author(s):  
Dan Robotham ◽  
Michael King ◽  
Anton Canagasabey ◽  
Sophie Inchley-Mort ◽  
Angela Hassiotis
BMJ ◽  
1995 ◽  
Vol 310 (6972) ◽  
pp. 125-126 ◽  
Author(s):  
S. Shepperd ◽  
C. Jenkinson ◽  
P. Morgan

Trials ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Caroline French ◽  
Hilary Pinnock ◽  
Gordon Forbes ◽  
Imogen Skene ◽  
Stephanie J. C. Taylor

Abstract Background Process evaluations are increasingly conducted within pragmatic randomised controlled trials (RCTs) of health services interventions and provide vital information to enhance understanding of RCT findings. However, issues pertaining to process evaluation in this specific context have been little discussed. We aimed to describe the frequency, characteristics, labelling, value, practical conduct issues, and accessibility of published process evaluations within pragmatic RCTs in health services research. Methods We used a 2-phase systematic search process to (1) identify an index sample of journal articles reporting primary outcome results of pragmatic RCTs published in 2015 and then (2) identify all associated publications. We used an operational definition of process evaluation based on the Medical Research Council’s process evaluation framework to identify both process evaluations reported separately and process data reported in the trial results papers. We extracted and analysed quantitative and qualitative data to answer review objectives. Results From an index sample of 31 pragmatic RCTs, we identified 17 separate process evaluation studies. These had varied characteristics and only three were labelled ‘process evaluation’. Each of the 31 trial results papers also reported process data, with a median of five different process evaluation components per trial. Reported barriers and facilitators related to real-world collection of process data, recruitment of participants to process evaluations, and health services research regulations. We synthesised a wide range of reported benefits of process evaluations to interventions, trials, and wider knowledge. Visibility was often poor, with 13/17 process evaluations not mentioned in the trial results paper and 12/16 process evaluation journal articles not appearing in the trial registry. Conclusions In our sample of reviewed pragmatic RCTs, the meaning of the label ‘process evaluation’ appears uncertain, and the scope and significance of the term warrant further research and clarification. Although there were many ways in which the process evaluations added value, they often had poor visibility. Our findings suggest approaches that could enhance the planning and utility of process evaluations in the context of pragmatic RCTs. Trial registration Not applicable for PROSPERO registration


Medical Care ◽  
2001 ◽  
Vol 39 (6) ◽  
pp. 627-634 ◽  
Author(s):  
Morris Weinberger ◽  
Eugene Z. Oddone ◽  
William G. Henderson ◽  
David M. Smith ◽  
James Huey ◽  
...  

2019 ◽  
Vol 13 (3/4) ◽  
pp. 158-172
Author(s):  
Laura Paulauskaite ◽  
Angela Hassiotis ◽  
Afia Ali

Purpose Fidelity data in clinical trials are not only necessary for appraising the internal and external validity, but also could provide useful insights how to improve the application of an intervention in everyday settings. The purpose of this paper is to understand the current literature of fidelity measurements in complex interventions for people with intellectual disabilities (ID) and behaviours that challenge. Design/methodology/approach The electronic databases MEDLINE, Embase, PsycINFO, Web of Science and CINAHL Plus were searched for studies published between 1990 to 2017 that have mentioned fidelity in randomised controlled trials of complex interventions for people with ID and behaviours that challenge based on positive behaviour support or applied behaviour analysis principles. The authors also searched the grey literature and reference lists. Findings Five randomised controlled trials were included in the review. The authors found variable and inconsistent fidelity measurements reported in the studies. The most frequently provided fidelity elements found in four out of five studies were adherence of implementation, dose and some aspects of quality of delivery. Research limitations/implications Research recommendations for a standardised approach of measuring fidelity in such studies are suggested. Originality/value The first review of such type that confirms the paucity of research measuring fidelity in complex interventions in this population.


2020 ◽  
pp. 103985622093614
Author(s):  
Steve Kisely

There are challenges to conducting randomised controlled trials in psychotherapy. This article therefore discusses methodological advances in applying this design to the field. The application of evidence-based practice to psychotherapy means that people with psychological problems, clinicians, health services and any third-party payers can confidently choose from a range of effective treatments that are best suited to an individual’s needs.


Sign in / Sign up

Export Citation Format

Share Document